Porphyromonas gingivalis disturbs host–commensal homeostasis by changing complement function

References

• Socransky SS, Haffajee AD. Evidence of bacterial etiology: a historical perspective. Periodontol 2000. 1994;5:1–11.
   Google Scholar
• Curtis M. The oral commensal microbiota bites back through Nod1. Cell Host Microbe. 2013;13:503–505.
   Web of Science ®Google Scholar
• Darveau RP, Hajishengallis G, Curtis MA. Porphyromonas gingivalis as a potential community activist for disease. J Dent Res. 2012;91:816–820.
   PubMed Web of Science ®Google Scholar
• Diaz PI, Hoare A, Hong BY. Subgingival microbiome shifts and community dynamics in periodontal diseases. J Calif Dent Assoc. 2016;44:421–435.
   PubMedGoogle Scholar
• Lamont RJ, Hajishengallis G. Polymicrobial synergy and dysbiosis in inflammatory disease. Trends Mol Med. 2015;21:172–183.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol. 2012;10:717–725.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G. The inflammophilic character of the periodontitis-associated microbiota. Mol Oral Microbiol. 2014;29:248–257.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the Polymicrobial Synergy and Dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012;27:409–419.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lamont RJ. Dancing with the stars: how choreographed bacterial interactions dictate nososymbiocity and give rise to keystone pathogens, accessory pathogens, and pathobionts. Trends Microbiol. 2016;24:477–489.
   PubMed Web of Science ®Google Scholar
• Varela JC, Tomlinson S. Complement: an overview for the clinician. Hematol Oncol Clin North Am. 2015;29:409–427.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Hajishengallis G, Yang K, et al. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785–797.
   PubMed Web of Science ®Google Scholar
• Bottazzi B, Doni A, Garlanda C, et al. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157–183.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lambris JD. More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol Rev. 2016;274:233–244.
   PubMed Web of Science ®Google Scholar
• Freeley S, Kemper C, Le Friec G. The “ins and outs” of complement-driven immune responses. Immunol Rev. 2016;274:16–32.
   PubMed Web of Science ®Google Scholar
• Hovingh ES, van den Broek B, Jongerius I. Hijacking complement regulatory proteins for bacterial immune evasion. Front Microbiol. 2016;7:2004.
   PubMed Web of Science ®Google Scholar
• Holt SC, Ebersole JL. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000. 2005;38:72–122.
   PubMed Web of Science ®Google Scholar
• Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25:134–144.
   PubMed Web of Science ®Google Scholar
• Dewhirst FE, Chen T, Izard J, et al. The human oral microbiome. J Bacteriol. 2010;192:5002–5017.
   PubMed Web of Science ®Google Scholar
• Kumar PS, Griffen AL, Moeschberger ML, et al. Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis. J Clin Microbiol. 2005;43:3944–3955.
   PubMed Web of Science ®Google Scholar
• Paster BJ, Boches SK, Galvin JL, et al. Bacterial diversity in human subgingival plaque. J Bacteriol. 2001;183:3770–3783.
   PubMed Web of Science ®Google Scholar
• Griffen AL, Beall CJ, Campbell JH, et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 2012;6:1176–1185.
   PubMed Web of Science ®Google Scholar
• Abusleme L, Dupuy AK, Dutzan N, et al. The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J. 2013;7:1016–1025.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15:30–44.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011;10:497–506.
   PubMed Web of Science ®Google Scholar
• Daep CA, Novak EA, Lamont RJ, et al. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii. Infect Immun. 2011;79:67–74.
   PubMed Web of Science ®Google Scholar
• Hendrickson EL, Wang T, Dickinson BC, et al. Proteomics of Streptococcus gordonii within a model developing oral microbial community. BMC Microbiol. 2012;12:211.
   PubMed Web of Science ®Google Scholar
• Kuboniwa M, Hendrickson EL, Xia Q, et al. Proteomics of Porphyromonas gingivalis within a model oral microbial community. BMC Microbiol. 2009;9:98.
   PubMed Web of Science ®Google Scholar
• Whitmore SE, Lamont RJ. The pathogenic persona of community-associated oral streptococci. Mol Microbiol. 2011;81:305–314.
   PubMed Web of Science ®Google Scholar
• Power ME, Tilman D, Estes JA, et al. Challenges in the quest for keystones. BioScience. 1996;46:609–620.
   Web of Science ®Google Scholar
• Cyktor JC, Turner J. Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect Immun. 2011;79:2964–2973.
   PubMed Web of Science ®Google Scholar
• Blom AM, Hallström T, Riesbeck K. Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol Immunol. 2009;46:2808–2817. S0161-5890(09)00194-1 [pii].
   PubMed Web of Science ®Google Scholar
• Lambris JD, Ricklin D, Geisbrecht BV. Complement evasion by human pathogens. Nat Rev Microbiol. 2008;6:132–142.
   PubMed Web of Science ®Google Scholar
• Potempa J, Sroka A, Imamura T, et al. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr Protein Pept Sci. 2003;4:397–407.
   PubMed Web of Science ®Google Scholar
• Potempa J, Pike RN. Corruption of innate immunity by bacterial proteases. J Innate Immun. 2009;1:70–87.
   PubMed Web of Science ®Google Scholar
• Wingrove JA, DiScipio RG, Chen Z, et al. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem. 1992;267:18902–18907.
   PubMed Web of Science ®Google Scholar
• Potempa M, Potempa J. Protease-dependent mechanisms of complement evasion by bacterial pathogens. Biol Chem. 2012;393:873–888.
   PubMed Web of Science ®Google Scholar
• Popadiak K, Potempa J, Riesbeck K, et al. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J Immunol. 2007;178:7242–7250.
   Web of Science ®Google Scholar
• Potempa M, Potempa J, Kantyka T, et al. Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. Plos Pathog. 2009;5:e1000316.
   PubMed Web of Science ®Google Scholar
• Potempa M, Potempa J, Okroj M, et al. Binding of complement inhibitor C4b-binding protein contributes to serum resistance of Porphyromonas gingivalis. J Immunol. 2008;181:5537–5544.
   PubMed Web of Science ®Google Scholar
• Slaney JM, Gallagher A, Aduse-Opoku J, et al. Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement. Infect Immun. 2006;74:5352–5361.
   PubMed Web of Science ®Google Scholar
• Rangarajan M, Aduse-Opoku J, Paramonov N, et al. Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50. J Bacteriol. 2008;190:2920–2932.
   Web of Science ®Google Scholar
• O’Brien-Simpson NM, Pathirana RD, Walker GD, et al. Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect Immun. 2009;77:1246–1261.
   PubMed Web of Science ®Google Scholar
• Maekawa T, Krauss JL, Abe T, et al. Porphyromonas gingivalis manipulates complement and TLR signaling to uncouple bacterial clearance from inflammation and promote dysbiosis. Cell Host Microbe. 2014;15:768–778.
   PubMed Web of Science ®Google Scholar
• Wang M, Krauss JL, Domon H, et al. Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal. 2010;3:ra11.
   PubMed Web of Science ®Google Scholar
• Liang S, Krauss JL, Domon H, et al. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J Immunol. 2011;186:869–877.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Shakhatreh MA, Wang M, et al. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J Immunol. 2007;179:2359–2367.
   PubMed Web of Science ®Google Scholar
• Harokopakis E, Albzreh MH, Martin MH, et al. TLR2 transmodulates monocyte adhesion and transmigration via Rac1- and PI3K-mediated inside-out signaling in response to Porphyromonas gingivalis fimbriae. J Immunol. 2006;176:7645–7656.
   Web of Science ®Google Scholar
• Harokopakis E, Hajishengallis G. Integrin activation by bacterial fimbriae through a pathway involving CD14, Toll-like receptor 2, and phosphatidylinositol-3-kinase. Eur J Immunol. 2005;35:1201–1210.
   PubMed Web of Science ®Google Scholar
• Wang M, Shakhatreh MA, James D, et al. Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J Immunol. 2007;179:2349–2358.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G. Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? Microbes Infect. 2009;11:637–645.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Krauss JL, Jotwani R, et al. Differential capacity for complement receptor-mediated immune evasion by Porphyromonas gingivalis depending on the type of innate leukocyte. Mol Oral Microbiol. 2016. DOI:10.1111/omi.12161
   Web of Science ®Google Scholar
• El-Awady AR, Arce RM, Cutler CW. Dendritic cells: microbial clearance via autophagy and potential immunobiological consequences for periodontal disease. Periodontol 2000. 2015;69:160–180.
   Web of Science ®Google Scholar
• Maekawa T, Abe T, Hajishengallis E, et al. Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis. J Immunol. 2014;192:6020–6027.
   PubMed Web of Science ®Google Scholar
• Hasturk H, Kantarci A, Goguet-Surmenian E, et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol. 2007;179:7021–7029.
   PubMed Web of Science ®Google Scholar
• Eskan MA, Jotwani R, Abe T, et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol. 2012;13:465–473.
   PubMed Web of Science ®Google Scholar
• Moutsopoulos NM, Konkel J, Sarmadi M, et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17–driven inflammatory bone loss. Sci Transl Med. 2014;6:229ra40.
   PubMed Web of Science ®Google Scholar
• Mastellos DC, Yancopoulou D, Kokkinos P, et al. Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention. Eur J Clin Invest. 2015;45:423–440.
   PubMed Web of Science ®Google Scholar
• Maekawa T, Briones RA, Resuello RR, et al. Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3. J Clin Periodontol. 2016;43:238–249.
   PubMed Web of Science ®Google Scholar
• Darveau RP. The oral microbial consortium’s interaction with the periodontal innate defense system. DNA Cell Biol. 2009;28:389–395.
   PubMed Web of Science ®Google Scholar
• Cugini C, Klepac-Ceraj V, Rackaityte E, et al. Porphyromonas gingivalis: keeping the pathos out of the biont. J Oral Microbiol. 2013;5:19804.
   Web of Science ®Google Scholar
• Duran-Pinedo AE, Baker VD, Frias-Lopez J. The periodontal pathogen Porphyromonas gingivalis induces expression of transposases and cell death of Streptococcus mitis in a biofilm model. Infect Immun. 2014;82:3374–3382.
   Web of Science ®Google Scholar
• Yost S, Duran-Pinedo AE, Teles R, et al. Functional signatures of oral dysbiosis during periodontitis progression revealed by microbial metatranscriptome analysis. Genome Med. 2015;7.
   Web of Science ®Google Scholar
• Page RC, Lantz MS, Darveau R, et al. Immunization of Macaca fascicularis against experimental periodontitis using a vaccine containing cysteine proteases purified from Porphyromonas gingivalis. Oral Microbiol Immunol. 2007;22:162–168.
   PubMedGoogle Scholar
• Kesavalu L, Sathishkumar S, Bakthavatchalu V, et al. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun. 2007;75:1704–1712.
   PubMed Web of Science ®Google Scholar
• Kumar PS, Leys EJ, Bryk JM, et al. Changes in periodontal health status are associated with bacterial community shifts as assessed by quantitative 16S cloning and sequencing. J Clin Microbiol. 2006;44:3665–3673. 44/10/3665 [pii]10.1128/JCM.00317-06.
   PubMed Web of Science ®Google Scholar
• Doungudomdacha S, Rawlinson A, Douglas CW. Enumeration of Porphyromonas gingivalis, Prevotella intermedia and Actinobacillus actinomycetemcomitans in subgingival plaque samples by a quantitative-competitive PCR method. J Med Microbiol. 2000;49:861–874.
   PubMed Web of Science ®Google Scholar
• Griffen AL, Beall CJ, Campbell JH, et al. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 2012;6.
   Web of Science ®Google Scholar
• Hong BY, Furtado Araujo MV, Strausbaugh LD, et al. Microbiome profiles in periodontitis in relation to host and disease characteristics. Plos One. 2015;10:e0127077.
   PubMed Web of Science ®Google Scholar
• Marsh PD. Are dental diseases examples of ecological catastrophes? Microbiology. 2003;149:279–294.
   PubMed Web of Science ®Google Scholar
• Ai D, Huang R, Wen J, et al. Integrated metagenomic data analysis demonstrates that a loss of diversity in oral microbiota is associated with periodontitis. BMC Genomics. 2017;18:1041.
   PubMed Web of Science ®Google Scholar
• Rudney JD, Chen R. The vital status of human buccal epithelial cells and the bacteria associated with them. Arch Oral Biol. 2006;51:291–298.
   PubMed Web of Science ®Google Scholar
• Colombo AV, Silva CM, Haffajee A, et al. Identification of oral bacteria associated with crevicular epithelial cells from chronic periodontitis lesions. J Med Microbiol. 2006;55:609–615.
   PubMed Web of Science ®Google Scholar
• Bik EM, Long CD, Armitage GC, et al. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J. 2010;4:962–974.
   PubMed Web of Science ®Google Scholar
• Zaura E, Keijser BJ, Huse SM, et al. Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol. 2009;9:259.
   PubMed Web of Science ®Google Scholar
• Haffajee AD, Cugini MA, Tanner A, et al. Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J Clin Periodontol. 1998;25:346–353.
   Web of Science ®Google Scholar
• Wang BY, Wu J, Lamont RJ, et al. Negative correlation of distributions of Streptococcus cristatus and Porphyromonas gingivalisin subgingival plaque. J Clin Microbiol. 2009;47:3902–3906.
   Web of Science ®Google Scholar
• Xie H, Hong J, Sharma A, et al. Streptococcus cristatus ArcA interferes with Porphyromonas gingivalis pathogenicity in mice. J Periodontal Res. 2012;47:578–583.
   Web of Science ®Google Scholar
• Carlisle MD, Srikantha RN, Brogden KA. Degradation of human alpha- and beta-defensins by culture supernatants of Porphyromonas gingivalis strain 381. J Innate Immun. 2009;1:118–122.
   Web of Science ®Google Scholar
• Olsen I, Hajishengallis G. Major neutrophil functions subverted by Porphyromonas gingivalis. J Oral Microbiol. 2016;8:30936.
   PubMed Web of Science ®Google Scholar
• Hasegawa Y, Tribble GD, Baker HV, et al. Role of Porphyromonas gingivalis SerB in gingival epithelial cell cytoskeletal remodeling and cytokine production. Infect Immun. 2008;76:2420–2427. IAI.00156-08 [pii].
   PubMed Web of Science ®Google Scholar
• Taxman DJ, Swanson KV, Broglie PM, et al. Porphyromonas gingivalis mediates inflammasome repression in polymicrobial cultures through a novel mechanism involving reduced endocytosis. J Biol Chem. 2012;287:32791–32799.
   Web of Science ®Google Scholar
• Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013–1022.
   PubMed Web of Science ®Google Scholar
• Olsen I, Yilmaz O. Modulation of inflammasome activity by Porphyromonas gingivalis in periodontitis and associated systemic diseases. J Oral Microbiol. 2016;8:30385.
   PubMed Web of Science ®Google Scholar
• Moutsopoulos NM, Kling HM, Angelov N, et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun. 2012;39:294–303.
   PubMed Web of Science ®Google Scholar
• Jauregui CE, Wang Q, Wright CJ, et al. Suppression of T-cell chemokines by Porphyromonas gingivalis. Infect Immun. 2013;81:2288–2295.
   PubMed Web of Science ®Google Scholar
• Hayashi C, Papadopoulos G, Gudino CV, et al. Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen. J Immunol. 2012;189:3681–3688.
   Web of Science ®Google Scholar
• Olsen I, Taubman MA, Singhrao SK. Porphyromonas gingivalis suppresses adaptive immunity in periodontitis, atherosclerosis, and Alzheimer’s disease. J Oral Microbiol. 2016;8:33029.
   PubMed Web of Science ®Google Scholar
• Zenobia C, Hajishengallis G. Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 2000. 2015;69:142–159.
   PubMed Web of Science ®Google Scholar
• Dutzan N, Abusleme L, Bridgeman H, et al. On-going mechanical damage from mastication drives homeostatic Th17 cell responses at the oral barrier. Immunity. 2017;46:133–147.
   Web of Science ®Google Scholar
• Hajishengallis G, Chavakis T, Hajishengallis E, et al. Neutrophil homeostasis and inflammation: novel paradigms from studying periodontitis. J Leukoc Biol. 2015;98:539–548.
   Web of Science ®Google Scholar
• Hajishengallis G, Lambris JD. Complement and dysbiosis in periodontal disease. Immunobiology. 2012;217:1111–1116.
   Web of Science ®Google Scholar
• Mastellos DC, Ricklin D, Hajishengallis E, et al. Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention. Mol Oral Microbiol. 2016;31:3–17.
   Web of Science ®Google Scholar
• Lee C-T, Teles R, Kantarci A, et al. Resolvin E1 reverses experimental periodontitis and dysbiosis. J Immunol. 2016;197:2796–2806.
   PubMed Web of Science ®Google Scholar